MedPath

Study on the Central Mechanism of Tuina in Treatment of Knee Osteoarthritis

Phase 1
Conditions
Knee Osteoarthritis
Registration Number
ITMCTR2100004799
Lead Sponsor
Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Comply with KOA's diagnostic criteria of Chinese and Western medicine, and meanwhile the syndrome differentiation of Chinese medicine is of Qi stagnation and blood stasis syndrome;
2. Aged 50 to 75 years, male or female, left knee pain, right handed;
3. The Kellgren-Lawrence radiology score is II-III;
4. Knee joint pain lasts for more than 6 months;
5. VAS score >= 3 points;
6. Occupation: non-manual workers (such as teachers, corporate office staff, etc.), no daily violent lower limb activities;
7. Agree and sign the informed consent form.

Exclusion Criteria

1. People with damaged skin around the knee joint;
2. History of knee surgery, history of severe trauma;
3. Patients with diabetes, systemic infections, severe liver and kidney function abnormalities, malignant tumors and other diseases;
4. Those who have received other treatment measures within the past month;
5. Those who are allergic to celecoxib capsules;
6. Pregnant or lactating women;
7. People with mental disorders or cognitive dysfunction;
8. Suffer from gastrointestinal system symptoms: such as active gastrointestinal ulcer/bleeding, or recurrent ulcer/bleeding;
9. People with MRI contraindications such as lock-in phobia, pacemaker, defibrillator, cardiac stent, intrauterine device, etc.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pressure Pain Thresholds;MRI scan to obtain various modal parameters;
Secondary Outcome Measures
NameTimeMethod
Hamilton Anxiety Scale;Pain Catastrophizing Scale;Numerical rating scale;Hamilton Depression Scale;
© Copyright 2025. All Rights Reserved by MedPath